Impact of a Papillomavirus Vaccination Promotion Program in Middle School: Study Protocol for a Cluster Controlled Trial

Phuong Lien Tran, Emmanuel Chirpaz, Malik Boukerrou, Antoine Bertolotti, Phuong Lien Tran, Emmanuel Chirpaz, Malik Boukerrou, Antoine Bertolotti

Abstract

Background: On Reunion Island, incidence and mortality for uterine cervical cancer is high, yet coverage rate for human papillomavirus (HPV) vaccination is low.

Objective: The main objective of the study is to evaluate the impact of a health promotion program promoting HPV vaccination on the proportion of middle school girls who complete the full HPV vaccination schedule (2 or 3 doses) by the end of school year.

Methods: This study is a cluster controlled intervention study using a superiority design. A combined health promotion program will be offered containing information to students and parents, training of general practitioners, and free school-based vaccination (in a "health bus"). Children who attend this program will constitute the intervention group and will be compared to children from another middle school who will not attend the program constituting the control group.

Results: Recruitment began in October 2020. In the intervention school, of 780 students, 245 were randomly selected in the 12 classes. In the control school, 259 students out of 834 were randomly selected.

Conclusions: In this study, we explore the impact of a health promotion program combining information toward students, parents, and general practitioners with free school-based vaccination. We expect a significantly higher HPV vaccination coverage in the intervention school as compared to the control school, whether it be among girls or boys. The final implication would be an extension of this program in all middle schools on the Island and thus an increase in HPV vaccination coverage.

Trial registration: ClinicalTrials.gov NCT04459221; https://ichgcp.net/clinical-trials-registry/NCT04459221.

International registered report identifier (irrid): DERR1-10.2196/35695.

Keywords: HPV; HPV vaccine; cancer; cervical cancer; children; community education; girls; health promotion; intervention; middle school; mortality; papillomavirus; parent; patient education; program; promotion; protocol; public education; school; sexual health; student; training; uterine cervical cancer; vaccination; vaccination program; vaccine; women's health; youth.

Conflict of interest statement

Conflicts of Interest: None declared.

©Phuong Lien Tran, Emmanuel Chirpaz, Malik Boukerrou, Antoine Bertolotti. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 13.06.2022.

Figures

Figure 1
Figure 1
Initial participant timeline. HPV: human papillomavirus.
Figure 2
Figure 2
Participant timeline in the context of COVID-19, with meeting restrictions. HPV: human papillomavirus.
Figure 3
Figure 3
Intervention screenshots.

References

    1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Nov 12;68(6):394–424. doi: 10.3322/caac.21492. doi: 10.3322/caac.21492.
    1. Observatoire régionale de la santé La Réunion. Les cancers du col de l'utérus à La Réunion. 2010. [2022-05-10]. .
    1. Registres FRANCIM. [2022-05-10]. .
    1. Dépistage et prévention du cancer du col de l'utérus. 2013. [2022-05-10]. .
    1. Tran PL, Zafindraibe N, Ah-You N, Fernandez C, Arrivets P, Gérardin P, Michault A, Boukerrou M, Bertolotti A. Human papillomavirus genotyping on Reunion Island: a cross-sectional study of stored tissue samples. Eur J Obstet Gynecol Reprod Biol. 2020 Sep;252:294–299. doi: 10.1016/j.ejogrb.2020.07.001.S0301-2115(20)30441-3
    1. Drolet M, Bénard É, Pérez N, Brisson M, HPV Vaccination Impact Study Group Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis. Lancet. 2019 Aug 10;394(10197):497–509. doi: 10.1016/S0140-6736(19)30298-3. S0140-6736(19)30298-3
    1. Chow EP, Tabrizi SN, Fairley CK, Wigan R, Machalek DA, Regan DG, Hocking JS, Garland SM, Cornall AM, Atchison S, Bradshaw CS, McNulty A, Owen L, Marshall L, Russell DB, Kaldor JM, Chen MY. Prevalence of human papillomavirus in teenage heterosexual males following the implementation of female and male school-based vaccination in Australia: 2014-2017. Vaccine. 2019 Oct 31;37(46):6907–6914. doi: 10.1016/j.vaccine.2019.09.052.S0264-410X(19)31261-7
    1. Reisinger K, Block S, Lazcano-Ponce E, Samakoses R, Esser M, Erick J, Puchalski D, Giacoletti K, Sings H, Lukac S, Alvarez F, Barr E. Safety and persistent immunogenicity of a quadrivalent human papillomavirus types 6, 11, 16, 18 L1 virus-like particle vaccine in preadolescents and adolescents: a randomized controlled trial. Pediatr Infect Dis J. 2007 Mar;26(3):201–209. doi: 10.1097/01.inf.0000253970.29190.5a.
    1. Paul P, Fabio A. Literature review of HPV vaccine delivery strategies: considerations for school- and non-school based immunization program. Vaccine. 2014 Jan 09;32(3):320–326. doi: 10.1016/j.vaccine.2013.11.070.S0264-410X(13)01632-0
    1. Fregnani JHTG, Carvalho AL, Eluf-Neto J, Ribeiro KDCB, Kuil LDM, da Silva TA, Rodrigues SL, Mauad EC, Longatto-Filho A, Villa LL. A school-based human papillomavirus vaccination program in barretos, Brazil: final results of a demonstrative study. PLoS One. 2013 Apr 24;8(4):e62647. doi: 10.1371/journal.pone.0062647. PONE-D-12-38968
    1. Vanderpool RC, Breheny PJ, Tiller PA, Huckelby CA, Edwards AD, Upchurch KD, Phillips CA, Weyman CF. Implementation and evaluation of a school-based human papillomavirus vaccination program in rural Kentucky. Am J Prev Med. 2015 Aug;49(2):317–323. doi: 10.1016/j.amepre.2015.05.001.S0749-3797(15)00221-4
    1. Géodes: Santé Publique France—Couverture vaccinale pour papillomavirus. 2018. [2019-06-10]. .
    1. Observatoire régional de la santé de La Réunion. 2019. [2019-07-10]. .
    1. Blondel C, Barret A, Pelat C. Influence Of socioeconomic factors on human papillomavirus vaccine uptake in adolescent girls in France. Bulletin Epidémiologique Hebdomadaire. 2019;22-23:441–450.
    1. Ecollan M, Partouche H, Gilberg S. Vaccination contre le papillomavirus. Exercer. 2018;147:412–418.
    1. Newman PA, Logie CH, Lacombe-Duncan A, Baiden P, Tepjan S, Rubincam C, Doukas N, Asey F. Parents' uptake of human papillomavirus vaccines for their children: a systematic review and meta-analysis of observational studies. BMJ Open. 2018 Apr 20;8(4):e019206. doi: 10.1136/bmjopen-2017-019206. bmjopen-2017-019206
    1. Campana V, Cousin L, Terroba C, Alberti C. Interventions aiming at improving vaccine coverage of human papillomavirus vaccine. Bulletin épidémiologique hebdomadaire. 2019;22-23:431.
    1. Amélioration de la couverture vaccinale? Une expérimentation de rattrapage vaccinal en milieu scolaire dans les Vosges. 2018. [2019-09-10]. .
    1. Declaration of Helsinki 1989. [2022-05-19]. .
    1. Grandahl M, Rosenblad A, Stenhammar C, Tydén T, Westerling R, Larsson M, Oscarsson M, Andrae B, Dalianis T, Nevéus T. School-based intervention for the prevention of HPV among adolescents: a cluster randomised controlled study. BMJ Open. 2016 Jan 27;6(1):e009875. doi: 10.1136/bmjopen-2015-009875. bmjopen-2015-009875
    1. Zhang X, Wang Z, Ren Z, Li Z, Ma W, Gao X, Zhang R, Qiao Y, Li J. HPV vaccine acceptability and willingness-related factors among Chinese adolescents: a nation-wide study. Hum Vaccin Immunother. 2021 Apr 03;17(4):1025–1032. doi: 10.1080/21645515.2020.1812314.
    1. Davies C, Stoney T, Hutton H, Parrella A, Kang M, Macartney K, Leask J, McCaffery K, Zimet G, Brotherton JM, Marshall HS, Skinner SR, Study Group School-based HPV vaccination positively impacts parents' attitudes toward adolescent vaccination. Vaccine. 2021 Jul 05;39(30):4190–4198. doi: 10.1016/j.vaccine.2021.05.051. S0264-410X(21)00637-X
    1. Reiter PL, Stubbs B, Panozzo CA, Whitesell D, Brewer NT. HPV and HPV vaccine education intervention: effects on parents, healthcare staff, and school staff. Cancer Epidemiol Biomarkers Prev. 2011 Sep 23;20(11):2354–2361. doi: 10.1158/1055-9965.epi-11-0562.
    1. Gilkey MB, McRee A, Magnus BE, Reiter PL, Dempsey AF, Brewer NT. Vaccination confidence and parental refusal/delay of early childhood vaccines. PLoS One. 2016 Jul 8;11(7):e0159087. doi: 10.1371/journal.pone.0159087. PONE-D-16-02033
    1. Tran PL, Bruneteaux A, Lazaro G, Antoine B, Malik B. HPV vaccination hesitancy in Reunion Island. J Gynecol Obstet Hum Reprod. 2022 Feb;51(2):102277. doi: 10.1016/j.jogoh.2021.102277.S2468-7847(21)00214-2
    1. Dedecker F, de Bailliencourt T, Barau G, Fortier D, Robillard P, Roge-Wolter M, Djemili S, Gerardin P. Étude des facteurs de risques obstétricaux dans le suivi de 365 grossesses primipares adolescentes à l’île de la Réunion. Journal de Gynécologie Obstétrique et Biologie de la Reproduction. 2005 Nov;34(7):694–701. doi: 10.1016/s0368-2315(05)82903-5.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj